(Q36913248)

17 August 2017

1 reference

title

Update on HIV lymphoma (English)

1 reference

17 August 2017

Ariela Noy

1

1 reference

17 August 2017

publication date

1 September 2007

1 reference

17 August 2017

published in

Current Oncology Reports

1 reference

17 August 2017

volume

9

1 reference

17 August 2017

issue

5

1 reference

17 August 2017

page(s)

384-390

1 reference

A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy

17 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-007-0052-X

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

21 January 2018

1 reference

12 December 2020

HIV-associated lymphoma successfully treated with peripheral blood stem cell transplantation

1 reference

12 December 2020

Loss of EBNA1-specific memory CD4+ and CD8+ T cells in HIV-infected patients progressing to AIDS-related non-Hodgkin lymphoma.

1 reference

12 December 2020

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

1 reference

12 December 2020

1 reference

12 December 2020

Hepatitis C virus and non-Hodgkin's lymphoma: findings from the Swiss HIV Cohort Study

1 reference

12 December 2020

Antiviral and immunomodulatory treatment for AIDS-related primary central nervous system lymphoma: AIDS Malignancies Consortium pilot study 019.

1 reference

12 December 2020

Ganciclovir is associated with low or undetectable Epstein-Barr virus DNA load in cerebrospinal fluid of patients with HIV-related primary central nervous system lymphoma

1 reference

12 December 2020

Decreased number of granzyme B+ activated CD8+ cytotoxic T lymphocytes in the inflammatory background of HIV-associated Hodgkin's lymphoma.

1 reference

12 December 2020

1 reference

12 December 2020

Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection

1 reference

12 December 2020

High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology

1 reference

12 December 2020

Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm

1 reference

12 December 2020

Characterization of Immunologic and Virological Parameters in HIV‐Infected Patients with Primary Effusion Lymphoma during Antiblastic Therapy and Highly Active Antiretroviral Therapy

1 reference

12 December 2020

Beneficial effect of highly active antiretroviral therapy on the prognosis of AIDS-related systemic non-Hodgkin lymphomas

1 reference

12 December 2020

Elevated levels of soluble CD44 precede the development of AIDS-associated non-Hodgkin's B-cell lymphoma

1 reference

12 December 2020

Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology

1 reference

12 December 2020

Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma

1 reference

12 December 2020

Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia

1 reference

12 December 2020

Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma

1 reference

12 December 2020

The case for rituximab in AIDS-related lymphoma

1 reference

12 December 2020

Lesion size determines accuracy of thallium-201 brain single-photon emission tomography in differentiating between intracranial malignancy and infection in AIDS patients.

1 reference

12 December 2020

Epstein-Barr virus infection is predictive of CNS involvement in systemic AIDS-related non-Hodgkin's lymphomas.

1 reference

12 December 2020

T-cell immune reconstitution after hematopoietic stem cell transplantation for HIV-associated lymphoma.

1 reference

12 December 2020

Autologous stem cell transplantation for HIV-associated lymphoma

1 reference

12 December 2020

The management of meningeal lymphoma in patients with HIV in the era of HAART: intrathecal depot cytarabine is effective and safe

1 reference

12 December 2020

Variable problems in lymphomas: CASE 3. Spontaneous regression of HIV-associated Burkitt's lymphoma of the cecum

1 reference

12 December 2020

Recurrent and self-healing cutaneous monoclonal plasmablastic infiltrates in a patient with AIDS and Kaposi sarcoma.

1 reference

12 December 2020

Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials.

1 reference

12 December 2020

CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients

1 reference

12 December 2020

Hepatitis C infection is not associated with systemic HIV-associated non-hodgkin's lymphoma: A cohort study

1 reference

12 December 2020

Survival after cancer diagnosis in persons with AIDS.

1 reference

12 December 2020

1 reference

12 December 2020

HIV+ MALT lymphoma remission induced by highly active antiretroviral therapy alone

1 reference

12 December 2020

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

12 December 2020

Prognostic Factors and Outcome of Human Herpesvirus 8–Associated Primary Effusion Lymphoma in Patients With AIDS

1 reference

12 December 2020

Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia

1 reference

12 December 2020

Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART)

1 reference

12 December 2020

Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010.

1 reference

12 December 2020

Patients With HIV With Burkitt’s Lymphoma Have a Worse Outcome Than Those With Diffuse Large-Cell Lymphoma Also in the Highly Active Antiretroviral Therapy Era

1 reference

12 December 2020

High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plasmablastic diffuse large B-cell lymphoma

1 reference

12 December 2020

Advantages of flow cytometry immunophenotyping for the diagnosis of central nervous system non-Hodgkin's lymphoma in AIDS patients

1 reference

12 December 2020

1 reference

12 December 2020

Highly active antiretroviral therapy and outcome of AIDS-related Burkitt's lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study.

1 reference

12 December 2020

Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS

1 reference

12 December 2020

Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France

1 reference

12 December 2020

AIDS and associated malignancies

1 reference

12 December 2020

The liberation of CD44.

1 reference

12 December 2020

Simian virus 40 tumor antigen expression and immunophenotypic profile of AIDS-related non-Hodgkin's lymphoma

1 reference

12 December 2020

High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy

1 reference

12 December 2020

Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy.

1 reference

12 December 2020

10.1007/S11912-007-0052-X

Identifiers

DOI

1 reference

17 August 2017

1 reference